Autologous dendritic cell vaccination against HIV-1 induces changes in natural killer cell phenotype and functionality

/in , , /von
Weiterlesen

Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience

/in , , , /von
Weiterlesen

Glioblastoma treatment slowly moves towards change: novel druggable targets and translational horizons in 2022

/in , , , /von
Weiterlesen

[Association of autologous tumor lysate-loaded dendritic cell vaccination with extension of survival among patients with newly diagnosed and recurrent glioblastoma]

/in , , /von
Weiterlesen

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial

/in , , /von
Weiterlesen

Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination (DCVax-L) in glioblastoma: breakthrough or fata morgana?

/in , , /von
Weiterlesen

Dendritic cell vaccines improve the glioma microenvironment: Influence, challenges, and future directions

/in , , /von
Weiterlesen

Oncolytic Newcastle Disease Virus Co-Delivered with Modified PLGA Nanoparticles Encapsulating Temozolomide against Glioblastoma Cells: Developing an Effective Treatment Strategy

/in , , /von
Weiterlesen

Poster presentation at the annual meeting of the Association for Cancer Immunotherapy

/in , , , /von
Weiterlesen

Poster presentation at the International Symposium on Pediatric Neuro-Oncology

/in , , /von
Weiterlesen